Abstract

Sjögren's syndrome (SjS) is characterized by lymphocytic infiltration of exocrine glands, i.e. autoimmune epithelitis. Lymphocytes are central in SjS pathogenesis, with B-cell hyperactivity mediated by T-cells. B-cells are main targets of Epstein-Barr virus (EBV) infection, a frequently-suggested trigger for SjS. We aimed to evaluate how the EBV infection modulates B and T-cell subsets in SjS, including as controls Rheumatoid arthritis patients (RA) and healthy participants (HC). SjS patients presented decreased CXCR5+T-cells, although IL21-secreting Tfh and Tfc cells were increased. Tfc were positively correlated with ESSDAI scores, suggesting their relevant role in SjS pathogenesis. As previously described, SjS patients showed expanded circulating naïve B-cell compartments. SjS patients had a higher incidence of EBV-EA-D-IgG+ antibodies, characteristic of recent EBV-infection/reactivation. SjS patients with past infection or recent infection/reactivation showed increased CXCR3+Th1 and CXCR3+Tfh1 cells compared to those without active infection. SjS patients with a recent infection/reactivation profile presented increased transitional B-cells compared to patients with past infection and increased plasmablasts, compared to those without infection. Our results suggest EBV-infection contributes to B and T-cell differentiation towards the effector phenotypes typical of SjS. Local lymphocyte activation at ectopic germinal centres, mediated by Tfh and Tfc, can be EBV-driven, perpetuating autoimmune epithelitis, which leads to gland destruction in SjS.

Details

Title
Association between EBV serological patterns and lymphocytic profile of SjS patients support a virally triggered autoimmune epithelitis
Author
Barcelos Filipe 1   VIAFID ORCID Logo  ; Martins Catarina 2   VIAFID ORCID Logo  ; Monteiro, Ricardo 2   VIAFID ORCID Logo  ; Cardigos Joana 3   VIAFID ORCID Logo  ; Prussiani Tiziano 4 ; Sítima Miguel 4   VIAFID ORCID Logo  ; Alves Nuno 5   VIAFID ORCID Logo  ; Vaz-Patto José 6   VIAFID ORCID Logo  ; Cunha-Branco, Jaime 7   VIAFID ORCID Logo  ; Luís-Miguel, Borrego 8   VIAFID ORCID Logo 

 CHRC, Comprehensive Health Research Centre, Lisbon, Portugal; Universidade Nova de Lisboa, CEDOC, Chronic Diseases Research Center, Immunology, NOVA Medical School|FCM, Lisbon, Portugal (GRID:grid.10772.33) (ISNI:0000000121511713); Instituto Português de Reumatologia, Department of Rheumatology, Lisbon, Portugal (GRID:grid.10772.33); Hospital Cuf Descobertas, Department of Rheumatology, Lisbon, Portugal (GRID:grid.10772.33) 
 CHRC, Comprehensive Health Research Centre, Lisbon, Portugal (GRID:grid.10772.33); Universidade Nova de Lisboa, CEDOC, Chronic Diseases Research Center, Immunology, NOVA Medical School|FCM, Lisbon, Portugal (GRID:grid.10772.33) (ISNI:0000000121511713) 
 Hospital de Santo António Dos Capuchos, Department of Ophthalmology, Centro Hospitalar de Lisboa Central, Lisbon, Portugal (GRID:grid.413439.8) 
 Universidade Nova de Lisboa, CEDOC, Chronic Diseases Research Center, Immunology, NOVA Medical School|FCM, Lisbon, Portugal (GRID:grid.10772.33) (ISNI:0000000121511713) 
 Hospital de Santo António Dos Capuchos, Department of Ophthalmology, Centro Hospitalar de Lisboa Central, Lisbon, Portugal (GRID:grid.413439.8); Hospital Cuf Descobertas, Department of Ophthalmology, Lisbon, Portugal (GRID:grid.413439.8) 
 Instituto Português de Reumatologia, Department of Rheumatology, Lisbon, Portugal (GRID:grid.413439.8) 
 CHRC, Comprehensive Health Research Centre, Lisbon, Portugal (GRID:grid.413439.8); Universidade Nova de Lisboa, CEDOC, Chronic Diseases Research Center, Immunology, NOVA Medical School|FCM, Lisbon, Portugal (GRID:grid.10772.33) (ISNI:0000000121511713); Hospital Cuf Descobertas, Department of Rheumatology, Lisbon, Portugal (GRID:grid.10772.33); Hospital de Egas Moniz, Department of Rheumatology, Centro Hospitalar de Lisboa Ocidental, Lisbon, Portugal (GRID:grid.414462.1) (ISNI:0000 0001 1009 677X) 
 CHRC, Comprehensive Health Research Centre, Lisbon, Portugal (GRID:grid.414462.1); Universidade Nova de Lisboa, CEDOC, Chronic Diseases Research Center, Immunology, NOVA Medical School|FCM, Lisbon, Portugal (GRID:grid.10772.33) (ISNI:0000000121511713); Hospital da Luz, Department of Immunoalergy, Lisbon, Portugal (GRID:grid.414429.e) (ISNI:0000 0001 0163 5700) 
Publication year
2021
Publication date
2021
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2490851622
Copyright
© The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.